Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

63 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2026Mar 3 10:35 PMKLEIN JOSEPH III
Proposed Sale
65,345$77.07$5.0M

View →

Mar 3, 2026Mar 3 10:34 PMDevers Shannon L.
Proposed Sale
39,014$79.50$3.1M

View →

Feb 13, 2026Feb 14 12:40 AMEric SwayzeEVP Research
Sale
15,642$81.76$1.3M32,105(D)

View →

Feb 11, 2026Feb 14 12:40 AMLynne B ParshallDirector
Sale
5,000$82.72$413.6K56,344(D)

View →

Feb 13, 2026Feb 13 9:04 PMSwayze Eric
Proposed Sale
15,642$81.65$1.3M

View →

Feb 11, 2026Feb 11 9:02 PMPARSHALL B LYNNE
Proposed Sale
10,000$82.74$827.4K

View →

Feb 6, 2026Feb 10 10:04 PMBrett P MoniaDirector, Chief Executive Officer
Sale
29,430$85.79$2.5M254,497(D)

View →

Feb 6, 2026Feb 6 9:09 PMMonia Brett P
Proposed Sale
290,203$85.55$24.8M

View →

Feb 2, 2026Feb 4 9:06 PMBENNETT C FRANKEVP, Chief Scientific Officer
Sale
85,089$82.93$7.1M80,293(D)

View →

Jan 30, 2026Feb 3 1:52 AMEric SwayzeEVP Research
Sale
6,179$82.93$512.4K47,747(D)

View →

Jan 30, 2026Feb 3 1:52 AMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Sale
6,179$83.45$515.6K69,702(D)

View →

Jan 30, 2026Feb 3 1:51 AMPatrick R. O'NeilEVP CLO & General Counsel
Sale
6,179$83.53$516.2K71,983(D)

View →

Jan 30, 2026Feb 3 1:51 AMBrett P MoniaDirector, Chief Executive Officer
Sale
62,970$82.72$5.2M283,927(D)

View →

Jan 30, 2026Feb 3 1:51 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Sale
6,988$83.24$581.7K132,881(D)

View →

Jan 30, 2026Feb 3 1:51 AMBrian BirchlerEVP, Corp and Development Ops
Sale
6,179$83.03$513.0K66,247(D)

View →

Jan 30, 2026Feb 3 1:51 AMBENNETT C FRANKEVP, Chief Scientific Officer
Sale
5,885$82.95$488.1K100,293(D)

View →

Jan 30, 2026Feb 3 1:51 AMJoseph BaroldiEVP, Chief Business Officer
Sale
5,296$82.96$439.4K45,413(D)

View →

Feb 2, 2026Feb 2 9:22 PMBENNETT C FRANK
Proposed Sale
85,089$82.93$7.1M

View →

Jan 30, 2026Jan 31 1:50 AMBaroldi Joseph
Proposed Sale
5,296$83.02$439.7K

View →

Jan 30, 2026Jan 31 1:47 AMBirchler Brian
Proposed Sale
6,179$82.91$512.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 2, 2026Jan 21 1:20 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
7,500$79.6716,600(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
11,11920,830(D)

View →

Jan 15, 2026Jan 21 1:18 AMHolly B. KordasiewiczEVP, Chief Development Officer
Grant/Award
24,90045,730(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Option Exercise
7,01329,664(D)

View →

Jan 15, 2026Jan 21 1:18 AMKyle JenneEVP, Chf GL Pdt Str Ofcr
Grant/Award
35,475$0.0037,725(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Option Exercise
28,72955,940(D)

View →

Jan 15, 2026Jan 21 1:18 AMHOUGEN ELIZABETH LEVP, Finance & CFO
Grant/Award
47,245$0.0068,825(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Option Exercise
17,37743,029(D)

View →

Jan 15, 2026Jan 21 1:18 AMShannon L. DeversEVP, Chief Human Resources Ofc
Grant/Award
35,475$0.0052,704(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Option Exercise
20,08941,126(D)

View →

Jan 15, 2026Jan 21 1:18 AMBrian BirchlerEVP, Corp and Development Ops
Grant/Award
35,475$0.0050,801(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Option Exercise
21,05517,434(D)

View →

Jan 15, 2026Jan 21 1:18 AMBENNETT C FRANKEVP, Chief Scientific Officer
Grant/Award
35,475$0.0027,109(D)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
19,8875,474(I)

View →

Jan 15, 2026Jan 21 1:18 AMJoseph BaroldiEVP, Chief Business Officer
Grant/Award
39,375$0.009,374(I)

View →

← Previous

Page 3 of 3